This position paper presents facts and figures regarding the evolution of interactions between pharma companies and physicians, and makes practical recommendations to ensure regular and impactful interactions in the years to come
News
This new 434-slide report in English provides a documented, detailed and robust analysis of the French pharma...
This new position paper analyses the current situation and the market perspectives of the therapeutic cannabis in...
We are pleased to offer you this complete collection of 1,700+ pages, including 66 position papers and...